Glycerol Stocks ---Antibodies --- Inhibitors and Drugs ---Primers --- siRNA Oligos
Parkinson’s disease (PD) is a progressive movement disorder affecting about 1.8% of people over the age of 65, characterized by the degeneration of the midbrain dopaminergic neurons in the substantia nigra. It is predominantly a sporadic disease, but about 10% of cases can be attributed to Mendelian inheritance. Neurodegenerative diseases are often associated with decreased cancer risk. However PD patients have an increased risk of melanoma and it has been proposed that the two conditions may share some biological pathways.
LRRK2 is a multi-domain protein, which uniquely possesses both protein kinase and GTPase catalytic activities (ROC-COR domains). Autosomal dominant mutations of LRRK2 represent one of the principal genetic risk factors for Parkinson’s Disease (PD), which results in preferential loss of neuromelanin containing, dopaminergic neurons from the substantia nigra. The (patho)physiological roles of LRRK2 are currently unclear. However, it has been linked to the regulation of endolysosmal membrane trafficking through complex formation with other PD-related gene-products (Rab7L1 and Vps35). LRRK2 is also highly expressed in melanoma cells (that derive from skin melanocytes). Melanocytes specifically produce melanin within the lysosome-related organelles known as melanosomes, in a process referred to as melanogenesis.
Recently, it has been shown that LRRK2 regulates (inhibition) a subset of Rab GTPases. LRRK2 phosphorylates the GDP bound form of Rabs to maintain them in an inactive state.
Interestingly, amoe.
Interestingly, among those Rabs we can find several RAbs that have been implicated in melanosomes positioning and/ or maturation: Rab1A, Rab3A, Rab7A, Rab8A and Rab27A for positioning; Rab7A and Rab9A for melanosmes maturation. Rab7L1 that inuration. Rab7L1 that interacts with LRRK2 is also a substrate but has not been shown to be important for melanogenesis. On the contrary, Rab32 and Rab38 (that are very close to Rab7L1) are not LRRK2 substrates, but are implicated in melanogenesis (traffic of melanogenic enzymes).
This project aims to examine the substrates and function of LRRK2 in pigmented melanoma cells.
Copyright 2016© - Site designed by Leila Rochin